NEW YORK, Jan. 21, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of 4D Molecular Therapeutics, Inc. ("4D" or the "Company") (NASDAQ: FDMT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The...
Hence then, the article about shareholder alert pomerantz law firm investigates claims on behalf of investors of 4d molecular therapeutics inc fdmt was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 4D Molecular Therapeutics, Inc. - FDMT )
Also on site :
- 1979 Classic Named No. 1 Hit Song Became an Unconditional Timeless Anthem
- Trump calls war on Iran a ‘little diversion’
- IMF, World Bank say they are restoring ties with Venezuela